4.7 Article

DOSIMETRIC BENEFITS OF INTENSITY-MODULATED RADIOTHERAPY COMBINED WITH THE DEEP-INSPIRATION BREATH-HOLD TECHNIQUE IN PATIENTS WITH MEDIASTINAL HODGKIN'S LYMPHOMA

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2011.05.015

关键词

Hodgkin's lymphoma; Radiation therapy; Intensity-modulated radiotherapy; Deep-inspiration breath-hold radiotherapy; Involved-node radiotherapy

向作者/读者索取更多资源

Purpose: To assess the additional benefits of using the deep-inspiration breath-hold (DIBH) technique with intensity-modulated radiotherapy (IMRT) in terms of the protection of organs at risk for patients with mediastinal Hodgkin's disease. Methods and Materials: Patients with early-stage Hodgkin's lymphoma with mediastinal involvement were entered into the study. Two simulation computed tomography scans were performed for each patient: one using the free-breathing (FB) technique and the other using the DIBH technique with a dedicated spirometer. The clinical target volume, planning target volume (PTV), and organs at risk were determined on both computed tomography scans according to the guidelines of the European Organization for Research and Treatment of Cancer. In both cases, 30 Gy in 15 fractions was prescribed. The dosimetric parameters retrieved for the statistical analysis were PTV coverage, mean heart dose, mean coronary artery dose, mean lung dose, and lung V20. Results: There were no significant differences in PTV coverage between the two techniques (FB vs. DIBH). The mean doses delivered to the coronary arteries, heart, and lungs were significantly reduced by 15% to 20% using DIBH compared with FB, and the lung V20 was reduced by almost one third. The dose reduction to organs at risk was greater for masses in the upper part of the mediastinum. IMRT with DIBH was partially implemented in 1 patient. This combination will be extended to other patients in the near future. Conclusions: Radiation exposure of the coronary arteries, heart, and lungs in patients with mediastinal Hodgkin's lymphoma was greatly reduced using DIBH with IMRT. The greatest benefit was obtained for tumors in the upper part of the mediastinum. The possibility of a wider use in clinical practice is currently under investigation in our department. (C) 2012 Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy

Dan Ou, Julien Adam, Ingrid Garberis, Pierre Blanchard, France Nguyen, Antonin Levy, Odile Casiraghi, Philippe Gorphe, Ingrid Breuskin, Francois Janot, Stephane Temam, Jean-Yves Scoazec, Eric Deutsch, Yungan Tao

RADIOTHERAPY AND ONCOLOGY (2019)

Review Urology & Nephrology

Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay

Charlien Berghen, Maarten Albersen, Pierre Blanchard, Alberto Bossi, Alberto Briganti, Cesare Cozzarini, Karel Decaestecker, Valerie Fonteyne, Karin Haustermans, Steven Joniau, Daryl Lim Joon, Vincent Khoo, Paul L. Nguyen, Piet Ost, Geert Villeirs, Christof Vulsteke, Anthony Zietman, Gert De Meerleer

BJU INTERNATIONAL (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma

Elaine Johanna Limkin, Pierre Blanchard

BRITISH JOURNAL OF RADIOLOGY (2019)

Article Oncology

Brachytherapy: An overview for clinicians

Cyrus Chargari, Eric Deutsch, Pierre Blanchard, Sebastien Gouy, Helene Martelli, Florent Guerin, Isabelle Dumas, Alberto Bossi, Philippe Morice, Akila N. Viswanathan, Christine Haie-Meder

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Review Medicine, General & Internal

Nasopharyngeal carcinoma

Yu-Pei Chen, Anthony T. C. Chan, Quynh-Thu Le, Pierre Blanchard, Ying Sun, Jun Ma

LANCET (2019)

Article Oncology

Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer

Adnan Elhammali, Pierre Blanchard, Alison Yoder, Zhongxing Liao, Xiadong Zhang, X. Ronald Zhu, Pamela K. Allen, Melenda Jeter, James Welsh, Quynh-Nhu Nguyen

RADIOTHERAPY AND ONCOLOGY (2019)

Editorial Material Oncology

Are Individual patient data meta-analyses still needed today in oncology? A discussion focused on Head and Neck oncology

Pierre Blanchard, Anne Auperin, Jean-Pierre Pignon

ACTA ONCOLOGICA (2019)

Article Oncology

Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer

Etienne Dauzier, Benjamin Lacas, Pierre Blanchard, Quynh-Thu Le, Christian Simon, Gregory Wolf, Francois Janot, Masatoshi Horiuchi, Jeffrey S. Tobias, James Moon, John Simes, Vinay Deshmane, Jean-Jacques Mazeron, Samir Mehta, Branko Zaktonik, Minoru Tamura, Elizabeth Moyal, Lisa Licitra, Catherine Fortpied, Bruce G. Haffty, Maria Grazia Ghi, Vincent Gregoire, Jonathan Harris, Jean Bourhis, Anne Auperin, Jean-Pierre Pignon

ORAL ONCOLOGY (2019)

Article Otorhinolaryngology

Prognostic value and therapeutic implications of nodal involvement in head and neck mucosal melanoma

Antoine Moya-Plana, David Mangin, Pierre Blanchard, Rais Obongo, Odile Casiraghi, Francois Bidault, Stephane Temam, Caroline Robert, Philippe Gorphe

Summary: The study found that the cN status is not a prognostic factor in patients with resectable head and neck mucosal melanoma. Elective lymph node dissection should not be routinely performed in cN0 patients.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)

Letter Oncology

About Second malignancy (SM) in prostate cancer patients treated with SBRT and other contemporary radiation techniques by Edward Christopher Dee and colleagues

Pierre Blanchard, Michael J. Zelefsky, Alberto Bossi, Cyrus Chargari, Jean-Marc Cosset

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

Anaplastic Thyroid Carcinoma: An Update

Arnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, Pierre Blanchard, Dana Hartl, Benjamin Chevalier, Frederic Deschamps, Livia Lamartina, Ludovic Lacroix, Corinne Dupuy, Eric Baudin, Christine Do Cao, Julien Hadoux

Summary: Anaplastic thyroid carcinoma (ATC) is a rare and aggressive form of thyroid cancer with a poor prognosis. Improving the management of this deadly disease involves the use of molecular tests for targeted therapies, fast-track dedicated care pathways, and prompt initiation of treatment. Adjuvant chemo-radiotherapy is recommended for localized disease after surgery, while chemotherapy or targeted therapy combined with decompressive cervical radiotherapy is recommended for locally advanced or metastatic disease.

CANCERS (2022)

Review Oncology

Adjuvant or Salvage Radiation Therapy for Prostate Cancer after Prostatectomy: Current Status, Controversies and Perspectives

Mario Terlizzi, Elaine Johanna Limkin, Yasmina Moukasse, Pierre Blanchard

Summary: The management of patients with biochemical recurrence after prostatectomy has changed significantly in recent years. Close monitoring of prostate-specific antigen (PSA) and early salvage radiotherapy (RT) have become the standard of care. However, uncertainties remain regarding the management of high-risk patients and the role of imaging.

CANCERS (2022)

Article Oncology

A systematic literature review of definitions and classification systems for radiotherapy innovation: A first step towards building a value-based assessment tool for radiation oncology

Miet Vandemaele, Marianne Aznar, Pierre Blanchard, Josep M. Borras, Michelle Leech, Ajay Aggarwal, Yolande Lievens

Summary: In order to address the evaluation issue of radiotherapy innovations, the HERO project of ESTRO has initiated the development of a radiotherapy-specific value-based framework. A systematic literature search revealed no widely accepted definition or classification system for radiotherapy innovations. However, the unique properties of radiotherapy interventions can be used to categorize innovations in radiation oncology, but clear terminology denoting radiotherapy-specific characteristics is still needed.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

暂无数据